Mini review: The FDA-approved prescription drugs that induce ovulation in women with ovulatory problems

被引:5
|
作者
Sun, Chunlei [1 ]
Rong, Xi [2 ]
Cai, Yongqin [3 ]
Qiu, Song [4 ]
Farzaneh, Maryam [5 ]
机构
[1] Yidu Cent Hosp Weifang, Dept Pediat, Weifang, Peoples R China
[2] Yidu Cent Hosp Weifang, Dept Pharm, Weifang, Peoples R China
[3] Yidu Cent Hosp Weifang, Dept Gynaecol, Weifang, Peoples R China
[4] Weifang Peoples Hosp, Imaging Dept Brain Hosp, Weifang 261021, Peoples R China
[5] Ahvaz Jundishapur Univ Med Sci, Physiol Res Ctr, Ahvaz, Iran
关键词
FDA-approved drugs; in vitro fertilization; infertility; ovulation; polycystic ovary syndrome; FOLLICLE-STIMULATING-HORMONE; POLYCYSTIC-OVARY-SYNDROME; CLOMIPHENE CITRATE; CORIFOLLITROPIN ALPHA; BROMOCRIPTINE TREATMENT; FEMALE INFERTILITY; PREGNANCY RATE; LETROZOLE; GONADOTROPINS; METFORMIN;
D O I
10.1002/ddr.21687
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Infertility is defined as not being able to become pregnant after 12 months or more of unprotected sexual intercourse. Female infertility as a serious health issue can result from ovulation disorders, menstrual cycle problems, structural problems, and environmental factors. Ovulation occurs once a month between the time of menarche and menopause. The release of a mature egg from the ovary is controlled with the hypothalamic-pituitary-ovarian axis. Several hormones such as gonadotropin-releasing hormone (GnRH), FSH (follicle-stimulating hormone), LH (luteinizing hormone), estrogen, and progesterone play fundamental roles in the ovulation process. Both FSH and LH are the main treatment for women with ovulation disorders. Depending on the reasons for infertility, several different types of treatment are available for infertile women. Fertility drugs as an important part of treatment work like the natural hormones to treat infertility. Several fertility drugs can regulate ovulation and the release of an egg from the ovary in women with polycystic ovary syndrome (PCOS) or undergoing in vitro fertilization (IVF) treatment. This mini-review is about the FDA-approved prescription drugs that induce ovulation in women with ovulatory problems.
引用
收藏
页码:815 / 822
页数:8
相关论文
共 50 条
  • [41] A Review of FDA-Approved Multi-Target Angiogenesis Drugs for Brain Tumor Therapy
    Buzatu, Iuliana Mihaela
    Tataranu, Ligia Gabriela
    Duta, Carmen
    Stoian, Irina
    Alexandru, Oana
    Dricu, Anica
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (05)
  • [42] Unraveling the synthesis and therapeutic potential of FDA-approved Alzheimer's drugs: A comprehensive review
    Rani, Anjali
    Khan, Javed
    Choudhary, Lakshika
    Kumar, Manas
    Jha, Ayushi
    Pandey, Garima
    Nand, Bhaskara
    TETRAHEDRON, 2025, 175
  • [43] Primary Care Physicians' Use of FDA-Approved Prescription Drug Labels
    Sullivan, Helen W.
    O'Donoghue, Amie C.
    Aikin, Kathryn J.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2014, 27 (05) : 694 - 698
  • [44] Evaluating physiochemical properties of FDA-approved orally administered drugs
    Reese, Tanner C.
    Devineni, Anvita
    Smith, Tristan
    Lalami, Ismail
    Ahn, Jung-Mo
    Raj, Ganesh V.
    EXPERT OPINION ON DRUG DISCOVERY, 2024, 19 (02) : 225 - 238
  • [45] FDA-Approved Anti-Obesity Drugs in the United States
    Daneschvar, Homayoun L.
    Aronson, Mark D.
    Smetana, Gerald W.
    AMERICAN JOURNAL OF MEDICINE, 2016, 129 (08): : 879.e1 - 879.e6
  • [46] Possible FDA-approved drugs to treat Ebola virus infection
    Shu Yuan
    Infectious Diseases of Poverty, 4
  • [47] Pharmacological Profile of FDA-Approved Orphan Drugs in the Year 2022
    Goyal, Parveen Kumar
    Sangwan, Kavita
    CURRENT PHARMACOLOGY REPORTS, 2024, 10 (02) : 96 - 120
  • [48] Repurposing FDA-approved drugs for anti-aging therapies
    Snell, Terry W.
    Johnston, Rachel K.
    Srinivasan, Bharath
    Zhou, Hongyi
    Gao, Mu
    Skolnick, Jeffrey
    BIOGERONTOLOGY, 2016, 17 (5-6) : 907 - 920
  • [49] FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022
    Rizzo, Carla
    Amata, Sara
    Pibiri, Ivana
    Pace, Andrea
    Buscemi, Silvestre
    Piccionello, Antonio Palumbo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
  • [50] PREEMPTION EXEMPTION: FDA-APPROVED ABORTION DRUGS AFTER DOBBS
    Huber, Jared C.
    NOTRE DAME LAW REVIEW, 2023, 98 (05) : 2217 - 2255